Skip to the page

Data / Form D filings / Evommune, Inc.

Evommune, Inc.: Form D filings

Evommune, Inc., a company in Palo Alto, CA, filed 4 Form D notices with the SEC in 2025. The latest, on January 8, 2025, reports $115.5 million sold of a $115.5 million offering to 25 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1841 PAGE MILL RD, Palo Alto, CA, 94304
Phone
(650) 223-7745
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2020
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2044725

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 8, 2025New notice$115,499,956$115,499,95625Oct 30, 2024sec.gov
Jan 8, 2025New notice$57,500,000$57,500,00016Mar 28, 2023sec.gov
Jan 8, 2025New notice$84,449,985$81,799,952$2,650,03310Aug 31, 2021sec.gov
Jan 7, 2025New notice$12,462,474$12,462,47418Jun 22, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Derek DiRoccoDirector
Eugene BauerExecutive Officer, Director
Felice Verduyn-van WeegenDirector
Robert HopfnerDirector
Kyle CarverExecutive Officer
David CohenDirector
Gregory MossExecutive Officer
Francois BeaubienDirector
Benjamin McGrawDirector
Jeegar PatelExecutive Officer
Yuexin YuDirector
Janice DrewExecutive Officer
Luis PenaExecutive Officer, Director

Other companies in California that filed recently

Every Form D from the week of Jan 6, 2025 · All recent filings in California · All recent Other filings

Read from SEC EDGAR. Amount sold is what Evommune, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.